Yu Zhang

Yu Zhang

Auto-generated profile, based on publicly available information

Yu Zhang

School of Chemistry and Chemical Engineering, University of Surrey, Guildford GU2 7XH, UK

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2024 in Journal of the Franklin Institute
Verified
Journal Article
Closed access
XGXiaoyong Gao
Xiaoyong Gao
YZYu Zhang
Yu Zhang
JFJun Fu
Jun Fu
SLShuang Li
Shuang Li

9 January 2023 in The Canadian Journal of Chemical Engineering
Verified
Journal Article
Closed access
XGXiaoyong Gao
Xiaoyong Gao
YZYu Zhang
Yu Zhang
JZJunfeng Zhou
Junfeng Zhou

6 June 2025 in Computers & Chemical Engineering
Verified
Journal Article
Closed access
YZYu Zhang
Yu Zhang
YXYongrui Xiao
Yongrui Xiao
DTDimitrios Tsaoulidis
Dimitrios Tsaoulidis
TCTao Chen
Tao Chen

10 May 2026 in Chemical Engineering Research and Design
Verified
Journal Article
Closed access
YXYongrui Xiao
Yongrui Xiao
MZMengjia Zhu
Mengjia Zhu
YZYu Zhang
Yu Zhang
DTDimitrios Tsaoulidis
Dimitrios Tsaoulidis
TCTao Chen
Tao Chen

15 April 2026 in Advanced Intelligent Discovery
Verified
Journal Article
Open access
PDF file
YZYu Zhang
Yu Zhang
YXYongrui Xiao
Yongrui Xiao
CCChunlin Chen
Chunlin Chen
DTDimitrios Tsaoulidis
Dimitrios Tsaoulidis
Kai YangKai Yang
Kai Yang
TCTao Chen
Tao Chen
Formulating effective skin products requires navigating complex chemical mixtures,skin biophysical and biochemical properties and manufacturing processes, all under budgetary and time constraints. Controlling dermal permeation, a key driver of efficacy, often presents the primary development bottleneck. Conventional development methods are slow, hampered by low‐throughput, variable test assays (e.g., in vitro release and permeation testing) and limited access to biologically relevant in vitro skin models. This review argues for a shift towards autonomous, assay‐aware formulation design, outlining a closed‐loop framework that unifies intelligent candidate generation, automated experiment selection and robust analysis across a skin‐specific multi‐tiered assay strategy. The foundations of barrier transport and formulation behaviour are first synthesised. Key enabling technologies are then systematically surveyed, including automation technologies (e.g., microfluidic and modular platforms), automated analytics (e.g., chromatographic pipelines, auto‐sampling for diffusion cells) and artificial intelligence (e.g., hybrid mechanistic/data‐driven surrogates and constraint‐aware active learning). Building upon this foundation, a practical framework is discussed that foregrounds cross‐tier calibration between rapid screens and pivotal assay endpoints. Its workflow centres on model generalisation, uncertainty quantification and robust system orchestration. The goal is to provide a credible path towards faster, more reproducible and acceptance criteria‐aligned decisions for skin product formulation efficacy.

9 June 2026 in RSC Pharmaceutics
Verified
Journal Article
Open access
PDF file
YXYongrui Xiao
Yongrui Xiao
CCChunlin Chen
Chunlin Chen
YZYu Zhang
Yu Zhang
DTDimitrios Tsaoulidis
Dimitrios Tsaoulidis
TCTao Chen
Tao Chen
IVRT release rates (6 h, nylon membrane) correlate strongly with IVPT flux (30 h, Strat-M) across fifteen ibuprofen poloxamer-407 formulations (Pearson r = 0.95, R 2 = 0.92), supporting IVRT for early formulation screening.